PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury

Peer Review reports

Original Submission
22 Dec 2015	Submitted	Original manuscript
12 Jan 2016	Reviewed	Reviewer Report - M-Alain Babi
6 Feb 2016	Reviewed	Reviewer Report - Michael Borich
16 Mar 2016	Author responded	Author comments - Flora Hammond
Resubmission - Version 2
16 Mar 2016	Submitted	Manuscript version 2
3 May 2016	Author responded	Author comments - Flora Hammond
Resubmission - Version 3
3 May 2016	Submitted	Manuscript version 3
Publishing
23 May 2016	Editorially accepted
9 Jun 2016	Article published	10.1186/s12883-016-0609-0

Back to article page